A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy

• Main Authors: Kim, Y.H, Muro, K, Yasui, H, Chen, J.-S, Ryu, M.-H, Park, S.-H, Chu, K.-M, Choo, S.-P, Sanchez, T, DelaCruz, C, Mukhopadhyay, P, Lainas, I, Li, C.-P
• Other Authors: MEDICINE
• Format: Article
• Published: 2020
• Subjects: fluoropyrimidine derivative; ixabepilone; adjuvant therapy; adult; advanced cancer; alopecia; arthralgia; article; Asian; asthenia; bleeding; Chinese; constipation; continuous infusion; decreased appetite; diarrhea; drug dose reduction; drug efficacy; drug eruption; drug fatality; drug treatment failure; drug withdrawal; dysgeusia; fatigue; febrile neutropenia; female; fever; human; hypesthesia; Japanese; Korean; leukopenia; major clinical study; male; multicenter study; multiple cycle treatment; myalgia; nail disease; nausea; neutropenia; open study; peripheral neuropathy; phase 2 clinical trial; pneumonia; priority journal; progression free survival; pruritus; sensory neuropathy; sepsis; side effect; stomach cancer; stomatitis; thrombocytopenia; treatment outcome; vomiting; weight reduction; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epothilones; Female; Fluorouracil; Humans; Male; Middle Aged; Stomach Neoplasms; Tubulin Modulators
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/180819
• Institution: National University of Singapore

10.1007/s00280-012-1943-6